|
Kathryn A. Phillips PhD is Professor of Health Economics and Health Services Research at the University of California, San Francisco (UCSF). She holds appointments in the Department of Clinical Pharmacy at the UCSF School of Pharmacy, the UCSF Institute for Health Policy Studies, and the UCSF Comprehensive Cancer Center. Dr. Phillips received her PhD in Health Services Research and Policy Analysis with a specialty in Health Economics from the University of California-Berkeley, her Masters degree in Public Administration with an emphasis on Policy Analysis from Harvard University, and her BA in Psychology (with high honors) from the University of Texas at Austin. Dr. Phillips’ research focuses on how health care is organized, delivered, and financed in the US. She focuses on personalized medicine – specifically, targeting health care interventions to patients based on their genetics – and the impact of personalized medicine on clinical care, health economics, and health policy, particularly in the area of cancer screening and treatment. Dr. Phillips conducts cross-disciplinary research across the basic, clinical, and social sciences and also across academia, industry, and government. She is serving as the Principal Investigator on several NIH and foundation grants, has led or participated in approximately 35 funded research grants, and has had continuous funding from the NIH throughout her career. Dr Phillips recently submitted a Program Project Grant proposal for a 4 year, $6 million research program on Personalized Medicine for Colorectal and Breast Cancer to the National Cancer Institute, a 4-year, $1M proposal to NIH on New Methodologies for Assessing Value of Personalized Medicine, and a 2-year, $500K renewal proposal to Blue Shield of CA Foundation. Dr. Phillips serves as an adviser to many government and industry groups including the Institutes of Medicine; Food and Drug Administration; Secretary of Health and Human Services Office; Secretary’s Advisory Committee on Genetics, Health, and Society; the Centers for Disease Control and Prevention; the National Cancer Institutes; and the President’s Council of Advisors on Science and Technology as well as start-up companies and venture capital firms. She has published ~ 100 peer-reviewed articles in policy and clinical journals, including JAMA, New England Journal of Medicine, and Health Affairs. |
